Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.41% |
| 2 | Financials | 12.33% |
| 3 | Energy | 10.93% |
| 4 | Industrials | 10.41% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MGLN
526
DELISTED
Magellan Health Services, Inc.
MGLN
| $24.1M | 0.05% |
319,935
+201,398
| +170% | +$12.9M |
|
527
Trip.com Group
TCOM
$29B
| $24M | 0.05% |
600,003
+535,540
| +831% | +$23.4M |
|
528
Ingredion
INGR
$6.69B
| $24M | 0.05% |
191,884
+116,690
| +155% | +$14.7M |
|
|
GHDX
529
DELISTED
Genomic Health, Inc.
GHDX
| $23.9M | 0.05% |
813,051
+83,116
| +11% | +$2.53M |
|
530
Suncor Energy
SU
$78.8B
| $23.9M | 0.05% |
729,858
+329,858
| +82% | +$10.1M |
|
|
CLGX
531
DELISTED
Corelogic, Inc.
CLGX
| $23.7M | 0.05% |
642,262
+157,641
| +33% | +$6.1M |
|
|
NTUS
532
DELISTED
Natus Medical Inc
NTUS
| $23.6M | 0.05% |
+677,407
| New | +$26.6M |
|
533
PUT
Teva Pharmaceuticals
TEVA
$43B
| $23.6M | 0.05% |
+650,000
| New | +$26M |
|
|
FNSR
534
DELISTED
Finisar Corp
FNSR
| $23.4M | 0.05% |
774,006
-141,215
| -15% | -$4.34M |
|
535
Union Pacific
UNP
$184B
| $23.4M | 0.05% |
225,901
-6,036
| -3% | -$593K |
|
|
VR
536
DELISTED
Validus Hold Ltd
VR
| $23.4M | 0.05% |
424,669
+407,939
| +2,438% | +$21.6M |
|
537
AB InBev
BUD
$156B
| $23.3M | 0.05% |
220,746
+133,694
| +154% | +$15M |
|
538
HUB Group
HUBG
$2.46B
| $23.2M | 0.05% |
1,058,982
+493,746
| +87% | +$10.2M |
|
539
Roper Technologies
ROP
$41.1B
| $23.2M | 0.05% |
126,459
+120,986
| +2,211% | +$21.7M |
|
|
CMA
540
DELISTED
Comerica
CMA
| $23.1M | 0.05% |
339,242
-1,444,430
| -81% | -$84.6M |
|
|
NUVA
541
DELISTED
NuVasive, Inc.
NUVA
| $23.1M | 0.05% |
342,832
+298,816
| +679% | +$19.3M |
|
542
Acuity Brands
AYI
$10.1B
| $23.1M | 0.05% |
99,929
+51,056
| +104% | +$12.4M |
|
|
LSXMA
543
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $22.7M | 0.05% |
911,752
+228,182
| +33% | +$5.68M |
|
544
FMC
FMC
$1.41B
| $22.7M | 0.05% |
462,964
+427,113
| +1,191% | +$19.5M |
|
545
TTM Technologies
TTMI
$11.3B
| $22.7M | 0.05% |
1,663,131
+905,481
| +120% | +$11.8M |
|
546
Chemours
CC
$2.32B
| $22.7M | 0.05% |
1,025,480
+579,936
| +130% | +$11.9M |
|
547
Manhattan Associates
MANH
$12.4B
| $22.6M | 0.05% |
425,784
-29,750
| -7% | -$1.59M |
|
|
PARA
548
DELISTED
Paramount Global Class B
PARA
| $22.6M | 0.05% |
354,866
+277,179
| +357% | +$16.4M |
|
|
VMW
549
DELISTED
VMware, Inc
VMW
| $22.6M | 0.05% |
286,698
-263,147
| -48% | -$20.4M |
|
550
Hartford Financial Services
HIG
$37.6B
| $22.5M | 0.05% |
473,072
-1,057,812
| -69% | -$48.5M |
|
Similar funds
Israel Englander's Q4 2016 Portfolio in Review
As of Q4 2016, Israel Englander held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Israel Englander withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.
Against the trend, Israel Englander opened a new position in Target worth $175M.
- Israel Englander's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Israel Englander added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Israel Englander's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Israel Englander fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Israel Englander's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Israel Englander opened 858 new positions and closed 801 in Q4 2016.
- Israel Englander's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.